OLD Mission Capital LLC increased its position in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 477.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 13,904 shares of the exchange traded fund’s stock after purchasing an additional 11,496 shares during the quarter. OLD Mission Capital LLC’s holdings in SPDR S&P Biotech ETF were worth $1,252,000 at the end of the most recent quarter.
Other institutional investors have also recently bought and sold shares of the company. StoneX Group Inc. acquired a new position in shares of SPDR S&P Biotech ETF in the 4th quarter valued at $2,352,000. Tradewinds LLC. acquired a new position in SPDR S&P Biotech ETF in the fourth quarter worth about $509,000. Alliancebernstein L.P. acquired a new position in SPDR S&P Biotech ETF in the fourth quarter worth about $607,000. Edmond DE Rothschild Holding S.A. lifted its stake in SPDR S&P Biotech ETF by 21.9% during the fourth quarter. Edmond DE Rothschild Holding S.A. now owns 3,288 shares of the exchange traded fund’s stock worth $296,000 after purchasing an additional 590 shares during the period. Finally, Wellington Management Group LLP boosted its holdings in SPDR S&P Biotech ETF by 24.1% during the fourth quarter. Wellington Management Group LLP now owns 65,250 shares of the exchange traded fund’s stock valued at $5,876,000 after purchasing an additional 12,689 shares in the last quarter.
SPDR S&P Biotech ETF Trading Up 3.1 %
XBI stock opened at $80.59 on Thursday. The firm has a market cap of $5.08 billion, a P/E ratio of 11.47 and a beta of 1.00. SPDR S&P Biotech ETF has a 1-year low of $77.26 and a 1-year high of $105.47. The business’s 50 day moving average is $88.81 and its 200-day moving average is $93.53.
SPDR S&P Biotech ETF Cuts Dividend
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Further Reading
- Five stocks we like better than SPDR S&P Biotech ETF
- A Deeper Look at Bid-Ask Spreads
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- Bank Stocks – Best Bank Stocks to Invest In
- The 3 Most Talked About Investments on WallStreetBets Right Now
- Manufacturing Stocks Investing
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.